Back to Authors

Scheithauer, Bernd W.

A5110883848 | I1330342723

Mayo Clinic

Mayo Clinic

Citations 104

p53 in Nonneoplastic Central Nervous System Lesions: An Immunohistochemical and Genetic Sequencing Study

Neurosurgery | July 30, 2004 | Volume: 51 | Issue: 5 | Pages: 1246-1255

10.1097/00006123-200211000-00021 | PMID 12383370

Heterotopic Ossification of Peripheral Nerve (“Neuritis Ossificans”): Report of Two Cases

Neurosurgery | July 30, 2004 | Volume: 51 | Issue: 1 | Pages: 244-246

10.1097/00006123-200207000-00039 | PMID 12182426

Abstract OBJECTIVE AND IMPORTANCE Heterotopic ossification (“neuritis ossificans”) is among the least frequently encountered reactive lesions in peripheral nerves. Only two cases have been described previously, one in the median nerve of a 34-year-old man, and the other in the ulnar nerve of an adult woman. The architecture of this lesion is distinctly zonal. Consisting of a central fibroblastic core, an intervening zone of osteoid production, and a peripheral layer of ossification, the pattern is remarkably similar to that of myositis ossificans. This similarity and the occurrence of the process in superficial nerves have led to speculation that trauma plays a role in its pathogenesis; this hypothesis remains unproved. We describe two additional cases of neuritis ossificans. CLINICAL PRESENTATION One patient, a 41-year-old man, experienced pain and numbness in the left leg for several months but had no history of local trauma. A mass was detected in the saphenous nerve. The second patient, a 16-year-old boy, noted subacute onset of pain in the popliteal fossa and decreased sensation in the distribution of the lateral sural cutaneous nerve. A mass was found within the tibial nerve at the knee level. INTERVENTION In each patient, resection of the mass required sacrifice of a segment of the nerve. CONCLUSION In each patient, the mass was composed of fibrovascular tissue with osteoid and bone deposition arranged in a zonal pattern. The ossifying process was intraneural but encased rather than directly involving nerve fascicles. These exceptionally intact examples of neuritis ossificans underscore its resemblance to myositis ossificans. Nerve-sparing resection of such masses is not always possible.
Cerebral Phaeohyphomycosis

Neurosurgery | July 30, 2004 | Volume: 33 | Issue: 5 | Pages: 894-897

10.1097/00006123-199311000-00018

Choristoma of the Optic Nerve: Case Report

Neurosurgery | July 30, 2004 | Volume: 50 | Issue: 5 | Pages: 1125-1128

10.1097/00006123-200205000-00032 | PMID 11987274

Abstract OBJECTIVE AND IMPORTANCE: Optic nerve choristoma is a rare lesion composed of adipose tissue and smooth muscle involving the optic nerve. Few cases have been reported. CLINICAL PRESENTATION: A 20-year-old woman presented with a history of slowly progressive visual loss in the left eye. On T1-weighted magnetic resonance imaging studies, after frequency-selective fat saturation, an optic nerve mass was detected at the level of the optic canal with signal characteristics suggesting the diagnosis of optic nerve lipoma. INTERVENTION: At left frontotemporal craniotomy, the intracranial optic nerve appeared thin and atrophic proximally and was covered by abundant adipose tissue distally. Because no cleavage plane could be identified between the fatty lesion and the optic nerve, which appeared splayed within the adipose tissue, the nerve was resected after an intraoperative biopsy. The presence of two heterotopic mesodermal elements, a rim of adipose tissue admixed with bundles of mature smooth muscle, extending into the nerve septa, warranted a diagnosis of optic nerve choristoma. CONCLUSION: Optic nerve choristoma is an uncommon optic nerve lesion. Even if imaging studies are highly suggestive of the diagnosis, pathological confirmation is required because of the high adipose tissue content in the majority of cases. The lesion, most likely malformative and nonneoplastic in nature, can be the cause of progressive visual loss.
Metastatic Hepatocellular Carcinoma Presenting as Epidural Hematoma: Case Report

Neurosurgery | July 30, 2004 | Volume: 49 | Issue: 2 | Pages: 447-449

10.1097/00006123-200108000-00034 | PMID 11504122

Abstract OBJECTIVE AND IMPORTANCE A case of acutely symptomatic epidural hematoma caused by metastatic hepatocellular carcinoma (HCC) to the cranium is reported. This is a rare case of metastatic HCC without known primary presenting as an epidural hematoma. CLINICAL PRESENTATION The patient presented with an acute onset of headache, aphasia, and right hemiparesis 2 weeks after he experienced minor trauma to the cranium. An emergency computed tomographic scan of the head revealed the presence of a left parietal epidural hematoma. INTERVENTION An emergency evacuation of the epidural hematoma was performed, and metastatic HCC was diagnosed. CONCLUSION The patient's neurological deficits were reversed with surgical intervention, and he is now undergoing palliative chemotherapy. This was the first clinical manifestation of HCC in this patient. This case reaffirms the neurosurgeon's role in the complex, multidisciplinary care of patients with craniospinal metastasis.
Combined Oligodendroglioma/Pleomorphic Xanthoastrocytoma: A Probable Collision Tumor: Case Report

Neurosurgery | July 30, 2004 | Volume: 48 | Issue: 6 | Pages: 1358-1361

10.1097/00006123-200106000-00038 | PMID 11383742

Abstract OBJECTIVE AND IMPORTANCE We report the first case of combined oligodendroglioma and pleomorphic xanthoastrocytoma. CLINICAL PRESENTATION A female college student and competitive cross-country runner presented to the Mayo Clinic at age 18 years with complaints of progressive headache and visual disturbances. Neuroimaging revealed a heavily calcified left parieto-occipital mass with focal enhancement and remodeling of the overlying calvarium. INTERVENTION A histological examination of the nearly gross total resection specimen disclosed a low-grade oligodendroglioma discretely abutting a superficially situated focus of pleomorphic xanthoastrocytoma. Ten months thereafter, a recurrence was suspected on the basis of the detection of a new focus of nodular enhancement. This lesion stabilized after radiation therapy, and the patient is well, without apparent residual disease 2.8 years after surgery. CONCLUSION This unique neoplasm is presumed to represent a collision tumor, its biological behavior being similar to that of oligodendroglioma alone. However, the possibility of an unusual, mixed oligoastrocytoma with pleomorphic xanthoastrocytoma as the astrocytic component cannot be excluded entirely. Potentially, both components have the capacity for recurrence and anaplastic transformation.
Management of Malignant Pineal Germ Cell Tumors with Residual Mature Teratoma

Neurosurgery | July 30, 2004 | Volume: 48 | Issue: 3 | Pages: 518-523

10.1097/00006123-200103000-00011 | PMID 11270541

Abstract OBJECTIVE The treatment of intracranial mixed germ cell tumors presents a unique challenge, since eradication of malignant tumor by radiation and/or chemotherapy may spare the benign tumor component. We reviewed our surgical experience with residual malignant pineal germ cell tumors after neoadjuvant therapy. METHODS Between 1987 and 1997, 16 patients with malignant intracranial germ cell tumors were treated at the Mayo Clinic with a protocol of neoadjuvant chemotherapy and radiation therapy. After the diagnosis was confirmed by histopathological examination, all patients were treated with four cycles of etoposide and cisplatin as well as external beam radiation therapy (range, 3030–5940 cGy). Six patients had an incomplete response to therapy, as demonstrated by observation of residual tumor on magnetic resonance imaging scans. Initial pathology in these six patients was germinoma in four and combinations of yolk sac tumor, embryonal carcinoma, malignant teratoma, and germinoma in two. Two patients had synchronous pineal and suprasellar tumors, with leptomeningeal dissemination. Tumor markers were elevated in four of the six patients at presentation. RESULTS All patients with residual pineal tumors underwent surgical resection via an infratentorial, supracerebellar approach. Pathological examination revealed mature teratoma in five patients and amorphous debris in one patient. No patient had recurrent malignancy. Significant neurological morbidity occurred in one patient, with no mortality. At a mean follow-up of 23 months, no recurrence on magnetic resonance imaging has been documented. CONCLUSION Residual pineal tumor occurring after treatment of malignant intracranial germ cell tumor with neoadjuvant therapy is likely to be mature teratoma. Operative resection of these benign recurrences is safe and effective.
Aggressive Enterogenous Cyst with Extensive Craniospinal Spread: Case Report

Neurosurgery | July 30, 2004 | Volume: 44 | Issue: 2 | Pages: 401-404

10.1097/00006123-199902000-00098 | PMID 9932896

Results of Treatment of Pituitary Disease in Multiple Endocrine Neoplasia, Type I

Neurosurgery | July 30, 2004 | Volume: 39 | Issue: 2 | Pages: 273-279

10.1097/00006123-199608000-00008 | PMID 8832664

Intrasellar Paraganglioma Report of a Case in a Sibship of von Hippel-Lindau Disease

Neurosurgery | July 29, 2004 | Volume: 38 | Issue: 2 | Pages: 395-399

10.1097/00006123-199602000-00034 | PMID 8869071